Long non-coding RNA (lncRNA) signatures have emerged as important prognostic biomarkers in acute myeloid leukemia (AML), stratifying patients into high-risk and low-risk groups and thus providing valuable insights for personalized treatment strategies. The dev... ...

请注册登录后继续浏览